Lexicon Pharmaceuticals
LXRX • NASDAQ • Stock Fundamentals
Lexicon Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael S. Exton, with a market cap of $839.5M.
Market Cap$839.5M
Employees285.0
CEOMichael S. Exton
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 5, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Lexicon Pharmaceuticals FAQ
Common questions about Lexicon Pharmaceuticals
Lexicon Pharmaceuticals (LXRX) has a market capitalization of $839.5M and trades on NASDAQ.
Lexicon Pharmaceuticals has approximately 285 employees.